1. The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions
   Abdelhakim Bouyahya et al, 2022, Biomolecules CrossRef
2. Chromatin Dynamics in Digestive System Cancer: Commander and Regulator
   Zeru Li et al, 2022, Frontiers in Oncology CrossRef
3. Evaluation of genetic variants in nucleosome remodeling and deacetylase (NuRD) complex subunits encoding genes and gastric cancer susceptibility
   Yujuan Zhang et al, 2022, Archives of Toxicology CrossRef
4. Establishment, immunological analysis, and drug prediction of a prognostic signature of ovarian cancer related to histone acetylation
   Yujie Fang et al, 2022, Frontiers in Pharmacology CrossRef
5. CREPT Disarms the Inhibitory Activity of HDAC1 on Oncogene Expression to Promote Tumorigenesis
   Yajun Cao et al, 2022, Cancers CrossRef
6. Long non-coding RNAs as potential markers for occurrence, progression, and prognosis of gastric cancer
   Fang Li et al, 2020, World Chinese Journal of Digestology CrossRef
7. A quantitative structural analysis of AR-42 derivatives as HDAC1 inhibitors for the identification of promising structural contributors
   R. Kundu et al, 2022, SAR and QSAR in Environmental Research CrossRef
8. C/EBPα alleviates hepatic ischemia‐reperfusion injury by inhibiting endoplasmic reticulum stress via HDAC1‐mediated deacetylation of ATF4
   Rong Li et al, 2024, Journal of Biochemical and Molecular Toxicology CrossRef
9. A Data Science Approach for the Identification of Molecular Signatures of Aggressive Cancers
   Adriano Barbosa-Silva et al, 2022, Cancers CrossRef
10. Acetylation in Tumor Immune Evasion Regulation
    Jun Lu et al, 2021, Frontiers in Pharmacology CrossRef